Cholangiocarcinoma (CCA)


Hagit Baris-Feldman

Israel Emerges as Global Powerhouse in Rare Disease Research

TEL AVIV, Israel — On the 6th floor of Schneider Children’s Hospital in the Tel Aviv suburb of Petah Tikva, 30 children with Alagille syndrome and 2 with lysosomal acid lipase deficiency (LAL-D) receive specialized treatment from a trio of pediatric hepatologists. Across town, at Sheba Medical Center’s Edmond and Lily Safra Children’s Hospital, pediatric…
NORD t-shirts for sale

NORD Recognizes Progress in Fight Against Rare Disease With 2021 Rare Impact Awards

Under COVID-19’s lingering shadow, the National Organization of Rare Disorders (NORD) has presented its 2021 Rare Impact Awards to 24 pharmaceutical firms, researchers, politicians, and nonprofit groups for their efforts over the past year on behalf of patients with such illnesses. The virtual ceremony was hosted by John Whyte, MD, MPH, chief medical officer at WebMD, with commentary…

Cholangiocarcinoma Clinical Insights

The Challenges of Lymphadenectomy in Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma is classified according to its occurrence along the biliary tree. For patients with intrahepatic cholangiocarcinoma, surgical resection is the only curative option. However, even post-surgery, intrahepatic cholangiocarcinoma is still associated with a high recurrence rate and poor survival.  Lymph node metastasis is one of the most significant prognostic indicators post-surgery. However, detecting lymph node…